HUMANIGEN, INC
DelistedCIK 1293310fmd_0PXE59EVGSEJTTP3T8PN3MZ4SRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2023, 49 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | 0 | 4 | 3 |
| Research and development | 33 | 27 | 17 | 10 | 11 | 2 | 3 | 73 | 213 | 55 |
| Total operating expenses | 41 | 37 | 34 | 19 | 19 | 11 | 9 | 89 | 236 | 71 |
| Operating income | (41) | (37) | (34) | (19) | (19) | (11) | (9) | (88) | (233) | (68) |
| Interest expense | 1 | 1 | 1 | 0 | 3 | 1 | 1 | 1 | 2 | 3 |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | (0) | (0) | 0 | 0 | 0 | (0) | (0) | (2) | 0 |
| Income tax expense | – | – | – | – | – | – | – | – | 22 | – |
| Net income | (42) | (38) | (35) | (27) | (22) | (12) | (10) | (90) | (237) | (71) |